Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Prognostic Utility of the ABCD-GENE Score in Asian ACS Patients
Author(s): Cheng Keat Tan , David Bin-Chia Wu , Seh Yi Joseph Tan , et al Added: 1 year ago

Anticoagulation

MI/ACS
Research Area(s) / Expertise:
Cha Rajakaruna
Job title: Consultant Cardiac Surgeon, Bristol Heart Institute, Bristol, UK
Mr. Cha Rajakaruna is a highly esteemed consultant cardiothoracic surgeon specializing in minimally invasive aortic valve replacement, coronary bypass surgery, atrial fibrillation, atrial fibrillation ablation, TAVI (transcatheter aortic valve implantation), and minimally invasive aortic valve repair. He currently practices at Spire Bristol Hospital.Mr. Rajakaruna earned his medical degree (MB… View more
Author(s): Byoung Geol Choi , Seung-Woon Rha , Se Yeon Choi , et al Added: 11 months ago

Anticoagulation
2024 ESC Atrial Fibrillation Guidelines: A Moving Goalpost
Author(s): Gheorghe-Andrei Dan , Antoni Martínez-Rubio Added: 4 months ago

Electrophysiology & Arrhythmia

Guidelines & Statements
Harry Crijns
Research Area(s) / Expertise:
Harry Crijns is a cardiologist with a specialization in cardiac arrhythmias. Dr Crijns obtained a PhD in 1993 on the medical treatment of atrial fibrillation (AF) and has since then achieved significant improvements in treatment through the introduction of care innovation and research by introducing risk scores CHA2DS2-VASc, HAS-BLED and the HATCH score. Dr Crijns is a member of the AER… View more
EHRA 24: A Substudy of NOAH-AFNET 6
Author(s): Julius Nikorowitsch Added: 1 year ago
EHRA 24 - We are joined onsite by Dr Julius Nikorowitsch (University Heart and Vascular Centre Hamburg (UHZ), DE) to outline the impact of age, sex, cardiovascular comorbidities, and kidney function on outcomes with oral anticoagulation therapy in patients with device-detected atrial fibrillation in a substudy of the NOAH-AFNET 6 trial (NCT02618577).The substudy consisted of 2534 patients from… View more

Electrophysiology & Arrhythmia
ESC 24: EPIC-CAD: Edoxaban vs Dual Antiplatelet Therapy in AF & CAD
Author(s): Gi-Byoung Nam , Min Soo Cho Added: 10 months ago
ESC Congress 2024 — Edoxaban monotherapy significantly improves outcomes in high-risk patients with CAD and atrial fibrillation.Investigators, Dr Gi-Byoung Nam (Ulsan University Hospital, Ulsan, SK) and Dr Min Soo Cho (Asan Medical Center, Seoul, SK) join us to discuss the key findings from the EPIC-CAD trial (NCT03718559).This Korean multi-centre, open-labelled, randomised controlled study… View more

Anticoagulation

Electrophysiology & Arrhythmia
ESC HF 25: The FIVE-STAR Trial
Author(s): Added: 1 month ago
ESC HF 25 - FIVE-STAR primary outcome is neutral, though finerenone was shown to significantly reduce UACR rates with a 29% greater reduction compared to placebo.We are joined by Dr Atsushi Tanaka (Saga University, Saga, JP) to discuss the findings from FIVE-STAR, a randomized trial investigating the effects of finerenone on vascular stiffness and cardiorenal biomarkers in patients with type 2… View more

Cardiovascular Renal Metabolic